What is Gilead Sciences, Inc. (GILD)'s PEG ratio?

Gilead Sciences, Inc. (GILD) has a PEG ratio of 0.12 (Potentially Undervalued), based on a PE ratio of 17.8 and expected EPS growth of 149.5% (5-Year EPS CAGR).

Is GILD undervalued based on its PEG ratio?

A PEG below 1.0 is conventionally read as potentially undervalued, 1.0–2.0 as fairly valued, and above 2.0 as potentially overvalued relative to growth. At 0.12, Gilead Sciences, Inc. (GILD) screens as "Potentially Undervalued". PEG is one signal, not investment advice — see the full DCF fair value at evidinvest.com/valuation/GILD.

Gilead Sciences, Inc. (GILD) PEG Ratio

Potentially Undervalued

PE ratio relative to earnings growth — is the valuation justified?

0.12

PEG Ratio

Growth rate exceeds 100% — PEG may be misleadingly low; treat with caution

0.12

Growth Rate Source

Good Data Quality5-Year EPS CAGR

Current Price

$130.52

TTM EPS

$7.34

P/E Ratio

17.78

Growth Rate

149.5%

5-Year EPS CAGR

Sector

Healthcare

Drug Manufacturers - General

Calculated

7/28/2026

7:32:25 PM

Peer Comparison

Sample Size

6 peers

Industry Median PEG

2.55

25th Percentile

1.55

75th Percentile

8.92

GILD PEG (0.12) vs Industry Median (2.55): 95% discount

Symbol	Company	PEG	P/E	Growth	vs GILD
AZN	AstraZeneca PLC	0.21	12.7	61.0%	+75%
LLY	Eli Lilly and Company	1.55	42.6	27.5%	+1200%
MRK	Merck & Co., Inc.	1.74	36.8	21.2%	+1360%
BMY	Bristol-Myers Squibb Company	3.37	17.6	5.2%	+2729%
AMGN	Amgen Inc.	8.92	26.2	2.9%	+7397%

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.

Gilead Sciences, Inc. (GILD) PEG Ratio

Peer Comparison

How to Interpret PEG Ratio

More on GILD

Compare with peers

Explore

Gilead Sciences, Inc. (GILD) PEG Ratio

Peer Comparison

How to Interpret PEG Ratio

More on GILD

Compare with peers

Explore